|
[1] 扆铁梅,吕志坚,孙艳艳,等. 日本创新务实的生物医药基地和园区构建. 科技情报开发与经济, 2011, 21(22): 113-114, 121. Yi T M, Lv Z J, Sun Y Y, et al. The construction of innovation and pragmatic biomedicine bases and parks in Japan. Sci-Tech Information development & Economy, 2011, 21(22): 113-114, 121.
[2] 王芳,曹阳,张文杰,等. 美国加州地区生物医药产业集群发展特点及借鉴意义. 中国医药技术经济与管理, 2009, 3(10): 53-59. Wang F, Cao Y, Zhang W J, et al. Development characteristics and references of biomedical industrial clusters in california, America. Chinese Journal of Pharmaceutical Technology Economics and Management, 2009, 3(10): 53-59.
[3] 张擎. 美国生物医药产业园区发展特点及启示. 中国高新区, 2011, 11(4): 111-113. Zhang Q. Development characteristics and inspiration of biomedical industrial parks in the US. Science & Technology Industry Parks, 2011, 11(4): 111-113.
[4] 肖光华,戴卫明. 产业集群与工业园区发展的案例研究——湖南浏阳生物医药园的成功经验分析. 技术经济, 2005, 23(2): 3-5. Xiao G H, Dai W M. Study on the case of clusters and industrial parks: analysis on successful experience of hunan liuyang biomedical industrial parks. Technology Economics, 2005, 23(2): 3-5
[5] 裴志东,谢明,韩宇. 从医药产业链角度浅析影响生物医药产业园区发展的瓶颈问题及对策研究. 中国卫生产业, 2011, 08(16): 28-29. Pei Z D, Xie M, Han Y. The bottleneck problems and development strategies of biomedical industry parks in the opinion of the pharmaceutical industry chain. China Health Industry, 2011, 08(16): 28-29.
[6] 苏月,张大璐,关镇和,等. 关于生物医药产业园区建设的思考. 中国生物工程杂志, 2011, 31(1): 109-112. Su Y, Zhang D L, Guan Z H, et al. A brief survey of building bio-pharmaceutical industrial parks. China Biotechnology, 2011, 31(1): 109-112.
|
